2020 Q4 Form 10-Q Financial Statement

#000117184321000175 Filed on January 08, 2021

View on sec.gov

Income Statement

Concept 2020 Q4 2019 Q4
Revenue $12.78M $14.63M
YoY Change -12.66% 3.81%
Cost Of Revenue $8.313M $9.805M
YoY Change -15.21% 3.64%
Gross Profit $4.466M $4.826M
YoY Change -7.47% 4.17%
Gross Profit Margin 34.95% 32.99%
Selling, General & Admin $4.836M $4.937M
YoY Change -2.05% -6.97%
% of Gross Profit 108.28% 102.29%
Research & Development $1.076M $961.6K
YoY Change 11.86% 10.26%
% of Gross Profit 24.09% 19.92%
Depreciation & Amortization $211.9K $211.1K
YoY Change 0.38% -3.03%
% of Gross Profit 4.75% 4.37%
Operating Expenses $5.911M $5.899M
YoY Change 0.22% -4.54%
Operating Profit $1.717M $1.580M
YoY Change 8.64% -16.24%
Interest Expense $2.368K $5.444K
YoY Change -56.5% 130.97%
% of Operating Profit 0.14% 0.34%
Other Income/Expense, Net
YoY Change
Pretax Income $1.780M $1.620M
YoY Change 9.88% -14.74%
Income Tax $378.6K $264.1K
% Of Pretax Income 21.27% 16.3%
Net Earnings $1.262M $1.213M
YoY Change 4.11% -19.0%
Net Earnings / Revenue 9.88% 8.29%
Basic Earnings Per Share $0.14 $0.13
Diluted Earnings Per Share $0.13 $0.13
COMMON SHARES
Basic Shares Outstanding 9.105M 9.096M
Diluted Shares Outstanding 9.645M 9.408M

Balance Sheet

Concept 2020 Q4 2019 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $13.34M $7.090M
YoY Change 88.15% 13.8%
Cash & Equivalents $6.953M $4.107M
Short-Term Investments $6.380M $2.990M
Other Short-Term Assets $920.0K $1.170M
YoY Change -21.37% -17.61%
Inventory $9.835M $11.26M
Prepaid Expenses $917.6K $1.170M
Receivables $10.23M $11.00M
Other Receivables $1.160M $1.440M
Total Short-Term Assets $35.48M $31.96M
YoY Change 11.0% 5.27%
LONG-TERM ASSETS
Property, Plant & Equipment $7.224M $7.346M
YoY Change -1.66% 4.07%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $24.96M $25.40M
YoY Change -1.74% 9.91%
Other Assets $552.1K $1.650M
YoY Change -66.54% 972.5%
Total Long-Term Assets $33.73M $35.97M
YoY Change -6.22% 9.12%
TOTAL ASSETS
Total Short-Term Assets $35.48M $31.96M
Total Long-Term Assets $33.73M $35.97M
Total Assets $69.21M $67.93M
YoY Change 1.88% 7.28%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $4.379M $4.119M
YoY Change 6.33% 2.0%
Accrued Expenses $2.440M $2.530M
YoY Change -3.56% 25.87%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $7.303M $6.706M
YoY Change 8.89% 8.3%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $280.0K $300.0K
YoY Change -6.67%
Total Long-Term Liabilities $276.0K $300.0K
YoY Change -7.99%
TOTAL LIABILITIES
Total Short-Term Liabilities $7.303M $6.706M
Total Long-Term Liabilities $276.0K $300.0K
Total Liabilities $7.579M $10.25M
YoY Change -26.06% 10.93%
SHAREHOLDERS EQUITY
Retained Earnings $43.74M $45.61M
YoY Change -4.12% 6.29%
Common Stock $17.81M $16.55M
YoY Change 7.65% 9.7%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $58.37M $57.67M
YoY Change
Total Liabilities & Shareholders Equity $69.21M $67.93M
YoY Change 1.88% 7.28%

Cashflow Statement

Concept 2020 Q4 2019 Q4
OPERATING ACTIVITIES
Net Income $1.262M $1.213M
YoY Change 4.11% -19.0%
Depreciation, Depletion And Amortization $211.9K $211.1K
YoY Change 0.38% -3.03%
Cash From Operating Activities $1.601M -$1.567M
YoY Change -202.17% 112.18%
INVESTING ACTIVITIES
Capital Expenditures $309.4K $197.4K
YoY Change 56.76% 85.67%
Acquisitions $0.00
YoY Change
Other Investing Activities -$840.0K $580.0K
YoY Change -244.83% -63.52%
Cash From Investing Activities -$1.178M $353.3K
YoY Change -433.39% -75.87%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $36.19K -$555.3K
YoY Change -106.52% 41.17%
NET CHANGE
Cash From Operating Activities $1.601M -$1.567M
Cash From Investing Activities -$1.178M $353.3K
Cash From Financing Activities $36.19K -$555.3K
Net Change In Cash $550.3K -$1.750M
YoY Change -131.45% -627.1%
FREE CASH FLOW
Cash From Operating Activities $1.601M -$1.567M
Capital Expenditures $309.4K $197.4K
Free Cash Flow $1.292M -$1.765M
YoY Change -173.2% 108.84%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2020Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2020Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
9104636
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
120000 USD
CY2020Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
90000 USD
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q4 us-gaap Preferred Stock No Par Value
PreferredStockNoParValue
0
CY2020Q3 us-gaap Preferred Stock No Par Value
PreferredStockNoParValue
0
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000
CY2020Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.02
CY2020Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.02
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
15000000
CY2020Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
15000000
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
9104636
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
9104636
CY2020Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
9099990
CY2020Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
9099990
CY2020Q4 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0
CY2019Q4 us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
0
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6953341 USD
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6403032 USD
CY2020Q4 us-gaap Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
6382785 USD
CY2020Q3 us-gaap Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
5544722 USD
CY2020Q4 ntic Trade Receivables Excluding Joint Ventures Net Current
TradeReceivablesExcludingJointVenturesNetCurrent
9551519 USD
CY2020Q3 ntic Trade Receivables Excluding Joint Ventures Net Current
TradeReceivablesExcludingJointVenturesNetCurrent
8072212 USD
CY2020Q4 ntic Trade Receivables Joint Ventures Current
TradeReceivablesJointVenturesCurrent
675391 USD
CY2020Q3 ntic Trade Receivables Joint Ventures Current
TradeReceivablesJointVenturesCurrent
475900 USD
CY2020Q4 ntic Fees Receivable For Services Provided To Joint Ventures Current
FeesReceivableForServicesProvidedToJointVenturesCurrent
1149165 USD
CY2020Q3 ntic Fees Receivable For Services Provided To Joint Ventures Current
FeesReceivableForServicesProvidedToJointVenturesCurrent
927286 USD
CY2020Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
10898 USD
CY2020Q3 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
19907 USD
CY2020Q4 us-gaap Inventory Gross
InventoryGross
9835135 USD
CY2020Q3 us-gaap Inventory Gross
InventoryGross
10961796 USD
CY2020Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
917570 USD
CY2020Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
797495 USD
CY2020Q4 us-gaap Assets Current
AssetsCurrent
35475804 USD
CY2020Q3 us-gaap Assets Current
AssetsCurrent
33202350 USD
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
7224297 USD
CY2019Q4 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
9805084 USD
CY2020Q4 us-gaap Gross Profit
GrossProfit
4465791 USD
CY2020Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
7110789 USD
CY2020Q4 us-gaap Equity Method Investments
EquityMethodInvestments
24961205 USD
CY2020Q3 us-gaap Equity Method Investments
EquityMethodInvestments
24090826 USD
CY2020Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
209220 USD
CY2020Q3 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
209729 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
782423 USD
CY2020Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
802006 USD
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
552103 USD
CY2020Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
658788 USD
CY2020Q4 ntic Assets Noncurrent Other Than Property Plant And Equipment
AssetsNoncurrentOtherThanPropertyPlantAndEquipment
26504951 USD
CY2020Q3 ntic Assets Noncurrent Other Than Property Plant And Equipment
AssetsNoncurrentOtherThanPropertyPlantAndEquipment
25761349 USD
CY2020Q4 us-gaap Assets
Assets
69205052 USD
CY2020Q3 us-gaap Assets
Assets
66074488 USD
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
4379475 USD
CY2020Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
3205241 USD
CY2020Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
486800 USD
CY2020Q3 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
310922 USD
CY2020Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1304018 USD
CY2020Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1314978 USD
CY2020Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
856532 USD
CY2020Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
880118 USD
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
276061 USD
CY2020Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
386345 USD
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
7302886 USD
CY2020Q3 us-gaap Liabilities Current
LiabilitiesCurrent
6097604 USD
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
276042 USD
CY2020Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
272443 USD
CY2020Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
276042 USD
CY2020Q3 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
272443 USD
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2020Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
182093 USD
CY2020Q3 us-gaap Common Stock Value
CommonStockValue
182000 USD
CY2020Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
17632811 USD
CY2020Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
17415043 USD
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
43735209 USD
CY2020Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
42472810 USD
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-3179678 USD
CY2020Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-3410438 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
58370435 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
56659415 USD
CY2020Q4 us-gaap Minority Interest
MinorityInterest
3255689 USD
CY2020Q3 us-gaap Minority Interest
MinorityInterest
3045026 USD
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
61626124 USD
CY2020Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
59704441 USD
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
69205052 USD
CY2020Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
66074488 USD
CY2020Q4 ntic Net Sales Excluding Joint Ventures
NetSalesExcludingJointVentures
12198808 USD
CY2019Q4 ntic Net Sales Excluding Joint Ventures
NetSalesExcludingJointVentures
14045784 USD
CY2020Q4 ntic Net Sales To Joint Ventures
NetSalesToJointVentures
580304 USD
CY2019Q4 ntic Net Sales To Joint Ventures
NetSalesToJointVentures
585616 USD
CY2020Q4 us-gaap Revenues
Revenues
12779112 USD
CY2019Q4 us-gaap Revenues
Revenues
14631400 USD
CY2020Q4 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
8313321 USD
CY2019Q4 us-gaap Gross Profit
GrossProfit
4826316 USD
CY2020Q4 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
1825712 USD
CY2019Q4 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
1293990 USD
CY2020Q4 ntic Fees For Services Provided To Joint Ventures
FeesForServicesProvidedToJointVentures
1336561 USD
CY2019Q4 ntic Fees For Services Provided To Joint Ventures
FeesForServicesProvidedToJointVentures
1358325 USD
CY2020Q4 us-gaap Other Operating Income
OtherOperatingIncome
3162273 USD
CY2019Q4 us-gaap Other Operating Income
OtherOperatingIncome
2652315 USD
CY2020Q4 us-gaap Selling Expense
SellingExpense
2741768 USD
CY2019Q4 us-gaap Selling Expense
SellingExpense
2887292 USD
CY2020Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2093982 USD
CY2019Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2049687 USD
CY2020Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1075737 USD
CY2019Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
961641 USD
CY2020Q4 us-gaap Operating Expenses
OperatingExpenses
5911487 USD
CY2019Q4 us-gaap Operating Expenses
OperatingExpenses
5898620 USD
CY2020Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
1716577 USD
CY2019Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
1580011 USD
CY2020Q4 us-gaap Investment Income Interest
InvestmentIncomeInterest
69538 USD
CY2019Q4 us-gaap Investment Income Interest
InvestmentIncomeInterest
49038 USD
CY2020Q4 us-gaap Interest Expense
InterestExpense
2368 USD
CY2019Q4 us-gaap Interest Expense
InterestExpense
5444 USD
CY2020Q4 us-gaap Income Loss Including Portion Attributable To Noncontrolling Interest
IncomeLossIncludingPortionAttributableToNoncontrollingInterest
1783747 USD
CY2019Q4 us-gaap Income Loss Including Portion Attributable To Noncontrolling Interest
IncomeLossIncludingPortionAttributableToNoncontrollingInterest
1623605 USD
CY2020Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
378590 USD
CY2019Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
264066 USD
CY2020Q4 us-gaap Profit Loss
ProfitLoss
1405157 USD
CY2019Q4 us-gaap Profit Loss
ProfitLoss
1359539 USD
CY2020Q4 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
142758 USD
CY2019Q4 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
146989 USD
CY2020Q4 us-gaap Net Income Loss
NetIncomeLoss
1262399 USD
CY2019Q4 us-gaap Net Income Loss
NetIncomeLoss
1212550 USD
CY2020Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.14
CY2019Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.13
CY2020Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.13
CY2019Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.13
CY2020Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9104623
CY2019Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9095607
CY2020Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9644630
CY2019Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9407642
CY2020Q4 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.00
CY2019Q4 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.065
CY2020Q4 us-gaap Profit Loss
ProfitLoss
1405157 USD
CY2019Q4 us-gaap Profit Loss
ProfitLoss
1359539 USD
CY2020Q4 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
298665 USD
CY2019Q4 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
125676 USD
CY2020Q4 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
1703822 USD
CY2019Q4 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
1485215 USD
CY2020Q4 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
210663 USD
CY2019Q4 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
169851 USD
CY2020Q4 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1493159 USD
CY2019Q4 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1315364 USD
CY2019Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
59669294 USD
CY2019Q4 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
0 USD
CY2019Q4 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
35607 USD
CY2019Q4 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
318818 USD
CY2019Q4 us-gaap Noncontrolling Interest Increase From Subsidiary Equity Issuance
NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance
0 USD
CY2019Q4 us-gaap Dividends
Dividends
590879 USD
CY2019Q4 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
1485215 USD
CY2019Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
60918055 USD
CY2020Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
59704441 USD
CY2020Q4 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
0 USD
CY2020Q4 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
36192 USD
CY2020Q4 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
181669 USD
CY2020Q4 us-gaap Noncontrolling Interest Increase From Subsidiary Equity Issuance
NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance
0 USD
CY2020Q4 us-gaap Dividends
Dividends
-0 USD
CY2020Q4 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
1703822 USD
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
61626124 USD
CY2020Q4 us-gaap Profit Loss
ProfitLoss
1405157 USD
CY2019Q4 us-gaap Profit Loss
ProfitLoss
1359539 USD
CY2020Q4 us-gaap Share Based Compensation
ShareBasedCompensation
181669 USD
CY2019Q4 us-gaap Share Based Compensation
ShareBasedCompensation
318818 USD
CY2020Q4 us-gaap Depreciation
Depreciation
211932 USD
CY2019Q4 us-gaap Depreciation
Depreciation
211132 USD
CY2020Q4 us-gaap Adjustment For Amortization
AdjustmentForAmortization
49989 USD
CY2019Q4 us-gaap Adjustment For Amortization
AdjustmentForAmortization
58521 USD
CY2020Q4 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
30000 USD
CY2019Q4 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
0 USD
CY2020Q4 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
1825712 USD
CY2019Q4 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
1293990 USD
CY2020Q4 us-gaap Proceeds From Dividends Received
ProceedsFromDividendsReceived
1125361 USD
CY2019Q4 us-gaap Proceeds From Dividends Received
ProceedsFromDividendsReceived
205432 USD
CY2020Q4 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-338 USD
CY2019Q4 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-114166 USD
CY2020Q4 ntic Increase Decrease In Trade Receivables Excluding Joint Ventures
IncreaseDecreaseInTradeReceivablesExcludingJointVentures
1334199 USD
CY2019Q4 ntic Increase Decrease In Trade Receivables Excluding Joint Ventures
IncreaseDecreaseInTradeReceivablesExcludingJointVentures
534080 USD
CY2020Q4 ntic Increase Decrease In Trade Receivables Joint Ventures
IncreaseDecreaseInTradeReceivablesJointVentures
199491 USD
CY2019Q4 ntic Increase Decrease In Trade Receivables Joint Ventures
IncreaseDecreaseInTradeReceivablesJointVentures
-182798 USD
CY2020Q4 ntic Increase Decrease In Fees Receivable For Services Provided To Joint Ventures
IncreaseDecreaseInFeesReceivableForServicesProvidedToJointVentures
221879 USD
CY2019Q4 ntic Increase Decrease In Fees Receivable For Services Provided To Joint Ventures
IncreaseDecreaseInFeesReceivableForServicesProvidedToJointVentures
97864 USD
CY2020Q4 us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
-10001 USD
CY2019Q4 us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
-262440 USD
CY2020Q4 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-1242101 USD
CY2019Q4 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
734384 USD
CY2020Q4 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
108751 USD
CY2019Q4 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
97035 USD
CY2020Q4 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1046577 USD
CY2019Q4 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
518930 USD
CY2020Q4 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
156951 USD
CY2019Q4 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
7970 USD
CY2020Q4 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-168924 USD
CY2019Q4 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-2049549 USD
CY2020Q4 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1601120 USD
CY2019Q4 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1567157 USD
CY2020Q4 us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
838063 USD
CY2019Q4 us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
2521837 USD
CY2020Q4 us-gaap Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
0 USD
CY2019Q4 us-gaap Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
3100000 USD
CY2020Q4 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
309400 USD
CY2019Q4 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
197370 USD
CY2020Q4 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
30406 USD
CY2019Q4 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
27493 USD
CY2020Q4 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1177869 USD
CY2019Q4 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
353300 USD
CY2020Q4 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
-0 USD
CY2019Q4 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
590878 USD
CY2020Q4 us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
36192 USD
CY2019Q4 us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
35607 USD
CY2020Q4 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
36192 USD
CY2019Q4 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-555271 USD
CY2020Q4 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
90866 USD
CY2019Q4 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
19166 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
550309 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1749962 USD
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
6403032 USD
CY2019Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
5856758 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
6953341 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
4106796 USD
CY2020Q4 us-gaap Description Of New Accounting Pronouncements Not Yet Adopted
DescriptionOfNewAccountingPronouncementsNotYetAdopted
<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><b><em style="font: inherit;">2.</em>      </b><span style="text-transform:uppercase;"><b>Accounting PronouncementS</b></span></p> <p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"> </p><p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"/> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><i>Recently Issued Accounting Pronouncements </i></p> <p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"> </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">In <em style="font: inherit;"> June 2016, </em>the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) <em style="font: inherit;">No.</em> <em style="font: inherit;">2016</em>-<em style="font: inherit;">13,</em> Measurement of Credit Losses on Financial Instruments, which revises guidance for the accounting for credit losses on financial instruments within its scope, and in <em style="font: inherit;"> November 2018, </em>issued ASU <em style="font: inherit;">No.</em> <em style="font: inherit;">2018</em>-<em style="font: inherit;">19</em> and in <em style="font: inherit;"> April 2019, </em>issued ASU <em style="font: inherit;">No.</em> <em style="font: inherit;">2019</em>-<em style="font: inherit;">04</em> and in <em style="font: inherit;"> May 2019, </em>issued ASU <em style="font: inherit;">No.</em> <em style="font: inherit;">2019</em>-<em style="font: inherit;">05,</em> and in <em style="font: inherit;"> November 2019, </em>issued ASU <em style="font: inherit;">No.</em> <em style="font: inherit;">2019</em>-<em style="font: inherit;">11,</em> which amended the standard. The new standard introduces an approach, based on expected losses, to estimate credit losses on certain types of financial instruments and modifies the impairment model for available-for-sale debt securities. The new approach to estimating credit losses (referred to as the current expected credit losses model) applies to most financial assets measured at amortized cost and certain other instruments, including trade and other receivables, loans, held-to-maturity debt securities, net investments in leases and off-balance-sheet credit exposures. This ASU is effective for fiscal years beginning after <em style="font: inherit;"> December 15, 2022, </em>including interim periods within those fiscal years, with early adoption permitted. Entities are required to apply the standard’s provisions as a cumulative-effect adjustment to retained earnings as of the beginning of the <em style="font: inherit;">first</em> reporting period in which the guidance is adopted. The Company is still evaluating the impact of this ASU.</p> <p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"/> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">Although there are several other new accounting pronouncements issued or proposed by the FASB, which the Company has adopted or will adopt, as applicable, the Company does <em style="font: inherit;">not</em> believe any of these accounting pronouncements has had or will have a material impact on the Company’s consolidated financial position or operating results.</p><p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"/> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </p>
CY2020Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
3180144 USD
CY2020Q3 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
3866791 USD
CY2020Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
6654991 USD
CY2020Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
7095005 USD
CY2020Q4 us-gaap Inventory Net
InventoryNet
9835135 USD
CY2020Q3 us-gaap Inventory Net
InventoryNet
10961796 USD
CY2020Q4 us-gaap Land
Land
310365 USD
CY2020Q3 us-gaap Land
Land
310365 USD
CY2020Q4 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
8245751 USD
CY2020Q3 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
8167783 USD
CY2020Q4 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
5111807 USD
CY2020Q3 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
4940912 USD
CY2020Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
13667923 USD
CY2020Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
13419060 USD
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
6443626 USD
CY2020Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
6308271 USD
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
7224297 USD
CY2020Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
7110789 USD
CY2019Q4 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.065
CY2020Q4 us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
0
CY2020Q4 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0
CY2019Q4 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0
CY2020Q3 us-gaap Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
4646
CY2019Q3 us-gaap Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
3597
CY2020Q4 us-gaap Net Income Loss
NetIncomeLoss
1262399 USD
CY2019Q4 us-gaap Net Income Loss
NetIncomeLoss
1212550 USD
CY2020Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9104623
CY2019Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9095607
CY2020Q4 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
540007
CY2019Q4 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
312035
CY2020Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9644630
CY2019Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9407642
CY2020Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.14
CY2019Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.13
CY2020Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.13
CY2019Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.13
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
419874
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
300770
CY2020Q4 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
181669 USD
CY2019Q4 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
318818 USD
CY2020Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
1149172 USD
CY2020Q4 ntic Allocated Share Based Compensation Expense Estimate Remainder Of Fiscal Year
AllocatedShareBasedCompensationExpenseEstimateRemainderOfFiscalYear
482505 USD
CY2020Q4 ntic Allocated Share Based Compensation Expense Estimate Fiscal Year Two
AllocatedShareBasedCompensationExpenseEstimateFiscalYearTwo
333334 USD
CY2020Q4 us-gaap Noncurrent Assets
NoncurrentAssets
7224297 USD
CY2020Q3 us-gaap Noncurrent Assets
NoncurrentAssets
7110789 USD
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.0237 pure
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.0215 pure
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.456 pure
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.451 pure
CY2020Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P10Y
CY2019Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P10Y
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0028 pure
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0157 pure
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
3.12
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
4.30
CY2020Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y10M24D
CY2019Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y9M10D
CY2020Q4 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 pure
CY2020Q4 us-gaap Revenues
Revenues
12779112 USD
CY2019Q4 us-gaap Revenues
Revenues
14631400 USD
CY2020Q4 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
8313321 USD
CY2019Q4 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
9805084 USD
CY2020Q4 us-gaap Revenues
Revenues
12779112 USD
CY2019Q4 us-gaap Revenues
Revenues
14631400 USD
CY2020Q4 ntic Total Fees For Services Provided To Joint Ventures Geographic Location
TotalFeesForServicesProvidedToJointVenturesGeographicLocation
1336561 USD
CY2020Q4 ntic Entity Wide Fees For Services Provided To Joint Ventures Geographic Percentage
EntityWideFeesForServicesProvidedToJointVenturesGeographicPercentage
1.000 pure
CY2019Q4 ntic Total Fees For Services Provided To Joint Ventures Geographic Location
TotalFeesForServicesProvidedToJointVenturesGeographicLocation
1358325 USD
CY2019Q4 ntic Entity Wide Fees For Services Provided To Joint Ventures Geographic Percentage
EntityWideFeesForServicesProvidedToJointVenturesGeographicPercentage
1.000 pure
CY2020Q4 us-gaap Revenues
Revenues
12779112 USD
CY2019Q4 us-gaap Revenues
Revenues
14631400 USD
CY2020Q4 us-gaap Accrued Bonuses Current And Noncurrent
AccruedBonusesCurrentAndNoncurrent
516667 USD
CY2019Q4 us-gaap Accrued Bonuses Current And Noncurrent
AccruedBonusesCurrentAndNoncurrent
400000 USD
CY2020Q4 ntic Entity Wide Trade Joint Venture Receivables Three Joint Ventures Percentage
EntityWideTradeJointVentureReceivablesThreeJointVenturesPercentage
0.556 pure
CY2019Q4 ntic Entity Wide Trade Joint Venture Receivables Three Joint Ventures Percentage
EntityWideTradeJointVentureReceivablesThreeJointVenturesPercentage
0.514 pure
CY2020Q4 us-gaap Available For Sale Securities
AvailableForSaleSecurities
6382785 USD
CY2020Q3 us-gaap Available For Sale Securities
AvailableForSaleSecurities
5544722 USD
CY2020Q4 us-gaap Interest Paid Net
InterestPaidNet
2368 USD
CY2019Q4 us-gaap Interest Paid Net
InterestPaidNet
5444 USD
CY2019Q4 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
0 USD
CY2020Q4 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
0 USD
CY2020Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
378590 USD
CY2019Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
264066 USD

Files In Submission

Name View Source Status
0001171843-21-000175-index-headers.html Edgar Link pending
0001171843-21-000175-index.html Edgar Link pending
0001171843-21-000175.txt Edgar Link pending
0001171843-21-000175-xbrl.zip Edgar Link pending
ex_219651.htm Edgar Link pending
ex_219652.htm Edgar Link pending
ex_219653.htm Edgar Link pending
ex_219654.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
ntic-20201130.xsd Edgar Link pending
ntic-20201130_cal.xml Edgar Link unprocessable
ntic-20201130_def.xml Edgar Link unprocessable
ntic-20201130_lab.xml Edgar Link unprocessable
ntic-20201130_pre.xml Edgar Link unprocessable
ntic20201130_10q.htm Edgar Link pending
ntic20201130_10q_htm.xml Edgar Link completed
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending